Neuropathic Pain Market Size, Trends, Analysis, and Outlook By Indication (Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-induced Peripheral Neuropathy, Others), By Drug Class (Tricyclic Antidepressants, Opioids, Capsaicin Cream, Steroids, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), by Country, Segment, and Companies, 2024-2032
The global Neuropathic Pain market size is poised to register 5.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neuropathic Pain market across By Indication (Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-induced Peripheral Neuropathy, Others), By Drug Class (Tricyclic Antidepressants, Opioids, Capsaicin Cream, Steroids, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others)
The neuropathic pain market is witnessing rapid growth driven by the increasing prevalence of chronic pain conditions, the growing understanding of neuropathic pain mechanisms, and advancements in pain management therapies, neuromodulation techniques, and targeted pharmacotherapies that provide relief from neuropathic pain symptoms, improve functional outcomes, and enhance quality of life for patients with neuropathic pain syndromes, diabetic neuropathy, and postherpetic neuralgia. With advancements in analgesic agents, neurostimulation devices, and gene therapy approaches, there is a rising opportunity for neuropathic pain stakeholders to offer personalized treatment approaches that address the underlying neurophysiological changes, neuroinflammatory processes, and central sensitization mechanisms while minimizing opioid reliance, treatment-related side effects, and treatment discontinuations for patients with chronic pain disorders. Further, the expanding pipeline of novel analgesics, disease-modifying agents, and non-pharmacological interventions, as well as the growing investment in pain research and multidisciplinary pain management programs, are driving market expansion further.
Neuropathic Pain Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Neuropathic Pain market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Neuropathic Pain survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Neuropathic Pain industry.
Key market trends defining the global Neuropathic Pain demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Neuropathic Pain Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Neuropathic Pain industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Neuropathic Pain companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Neuropathic Pain industry
Leading Neuropathic Pain companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Neuropathic Pain companies.
Neuropathic Pain Market Study- Strategic Analysis Review
The Neuropathic Pain market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Neuropathic Pain industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Neuropathic Pain Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Neuropathic Pain Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Neuropathic Pain market segments. Similarly, Strong market demand is encouraging Canadian Neuropathic Pain companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Neuropathic Pain market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Neuropathic Pain Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Neuropathic Pain industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Neuropathic Pain market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Neuropathic Pain Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Neuropathic Pain in Asia Pacific. In particular, China, India, and South East Asian Neuropathic Pain markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Neuropathic Pain Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Neuropathic Pain Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Neuropathic Pain market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Neuropathic Pain.
Neuropathic Pain Market Company Profiles
The global Neuropathic Pain market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Centaur Pharmaceuticals Pvt. Ltd, Cipla Ltd, Dr. Reddy's Laboratories Ltd, GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd, Grьnenthal GmbH, Lannett Co Inc, Laurus Labs, Lupin Ltd, Mallinckrodt Pharmaceuticals, Pfizer Inc, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd.
Recent Neuropathic Pain Market Developments
The global Neuropathic Pain market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Neuropathic Pain Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Indication
Diabetic Neuropathy
Spinal Stenosis
Chemotherapy-induced Peripheral Neuropathy
Others
By Drug Class
Tricyclic Antidepressants
Opioids
Capsaicin Cream
Steroids
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
Geographical Segmentation:
Centaur Pharmaceuticals Pvt. Ltd
Cipla Ltd
Dr. Reddy's Laboratories Ltd
GlaxoSmithKline plc
Glenmark Pharmaceuticals Ltd
Grьnenthal GmbH
Lannett Co Inc
Laurus Labs
Lupin Ltd
Mallinckrodt Pharmaceuticals
Pfizer Inc
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
Formats Available: Excel, PDF, and PPT
The neuropathic pain market is witnessing rapid growth driven by the increasing prevalence of chronic pain conditions, the growing understanding of neuropathic pain mechanisms, and advancements in pain management therapies, neuromodulation techniques, and targeted pharmacotherapies that provide relief from neuropathic pain symptoms, improve functional outcomes, and enhance quality of life for patients with neuropathic pain syndromes, diabetic neuropathy, and postherpetic neuralgia. With advancements in analgesic agents, neurostimulation devices, and gene therapy approaches, there is a rising opportunity for neuropathic pain stakeholders to offer personalized treatment approaches that address the underlying neurophysiological changes, neuroinflammatory processes, and central sensitization mechanisms while minimizing opioid reliance, treatment-related side effects, and treatment discontinuations for patients with chronic pain disorders. Further, the expanding pipeline of novel analgesics, disease-modifying agents, and non-pharmacological interventions, as well as the growing investment in pain research and multidisciplinary pain management programs, are driving market expansion further.
Neuropathic Pain Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Neuropathic Pain market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Neuropathic Pain survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Neuropathic Pain industry.
Key market trends defining the global Neuropathic Pain demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Neuropathic Pain Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Neuropathic Pain industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Neuropathic Pain companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Neuropathic Pain industry
Leading Neuropathic Pain companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Neuropathic Pain companies.
Neuropathic Pain Market Study- Strategic Analysis Review
The Neuropathic Pain market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Neuropathic Pain industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Neuropathic Pain Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Neuropathic Pain Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Neuropathic Pain market segments. Similarly, Strong market demand is encouraging Canadian Neuropathic Pain companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Neuropathic Pain market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Neuropathic Pain Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Neuropathic Pain industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Neuropathic Pain market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Neuropathic Pain Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Neuropathic Pain in Asia Pacific. In particular, China, India, and South East Asian Neuropathic Pain markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Neuropathic Pain Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Neuropathic Pain Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Neuropathic Pain market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Neuropathic Pain.
Neuropathic Pain Market Company Profiles
The global Neuropathic Pain market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Centaur Pharmaceuticals Pvt. Ltd, Cipla Ltd, Dr. Reddy's Laboratories Ltd, GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd, Grьnenthal GmbH, Lannett Co Inc, Laurus Labs, Lupin Ltd, Mallinckrodt Pharmaceuticals, Pfizer Inc, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd.
Recent Neuropathic Pain Market Developments
The global Neuropathic Pain market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Neuropathic Pain Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Indication
Diabetic Neuropathy
Spinal Stenosis
Chemotherapy-induced Peripheral Neuropathy
Others
By Drug Class
Tricyclic Antidepressants
Opioids
Capsaicin Cream
Steroids
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Centaur Pharmaceuticals Pvt. Ltd
Cipla Ltd
Dr. Reddy's Laboratories Ltd
GlaxoSmithKline plc
Glenmark Pharmaceuticals Ltd
Grьnenthal GmbH
Lannett Co Inc
Laurus Labs
Lupin Ltd
Mallinckrodt Pharmaceuticals
Pfizer Inc
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Neuropathic Pain Market Overview and Key Findings, 2024
1.2 Neuropathic Pain Market Size and Growth Outlook, 2021- 2030
1.3 Neuropathic Pain Market Growth Opportunities to 2030
1.4 Key Neuropathic Pain Market Trends and Challenges
1.4.1 Neuropathic Pain Market Drivers and Trends
1.4.2 Neuropathic Pain Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Neuropathic Pain Companies
2. NEUROPATHIC PAIN MARKET SIZE OUTLOOK TO 2030
2.1 Neuropathic Pain Market Size Outlook, USD Million, 2021- 2030
2.2 Neuropathic Pain Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. NEUROPATHIC PAIN MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. NEUROPATHIC PAIN MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Indication
Diabetic Neuropathy
Spinal Stenosis
Chemotherapy-induced Peripheral Neuropathy
Others
By Drug Class
Tricyclic Antidepressants
Opioids
Capsaicin Cream
Steroids
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Neuropathic Pain Market, 2025
5.2 Asia Pacific Neuropathic Pain Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Neuropathic Pain Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Neuropathic Pain Market, 2025
5.5 Europe Neuropathic Pain Market Size Outlook by Type, 2021- 2030
5.6 Europe Neuropathic Pain Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Neuropathic Pain Market, 2025
5.8 North America Neuropathic Pain Market Size Outlook by Type, 2021- 2030
5.9 North America Neuropathic Pain Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Neuropathic Pain Market, 2025
5.11 South America Pacific Neuropathic Pain Market Size Outlook by Type, 2021- 2030
5.12 South America Neuropathic Pain Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Neuropathic Pain Market, 2025
5.14 Middle East Africa Neuropathic Pain Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Neuropathic Pain Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Neuropathic Pain Market Size Outlook and Revenue Growth Forecasts
6.2 US Neuropathic Pain Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Neuropathic Pain Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Neuropathic Pain Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Neuropathic Pain Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Neuropathic Pain Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Neuropathic Pain Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Neuropathic Pain Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Neuropathic Pain Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Neuropathic Pain Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Neuropathic Pain Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Neuropathic Pain Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Neuropathic Pain Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Neuropathic Pain Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Neuropathic Pain Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Neuropathic Pain Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Neuropathic Pain Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Neuropathic Pain Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Neuropathic Pain Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Neuropathic Pain Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Neuropathic Pain Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Neuropathic Pain Industry Drivers and Opportunities
7. NEUROPATHIC PAIN MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. NEUROPATHIC PAIN COMPANY PROFILES
8.1 Profiles of Leading Neuropathic Pain Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Centaur Pharmaceuticals Pvt. Ltd
Cipla Ltd
Dr. Reddy's Laboratories Ltd
GlaxoSmithKline plc
Glenmark Pharmaceuticals Ltd
Grьnenthal GmbH
Lannett Co Inc
Laurus Labs
Lupin Ltd
Mallinckrodt Pharmaceuticals
Pfizer Inc
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Neuropathic Pain Market Overview and Key Findings, 2024
1.2 Neuropathic Pain Market Size and Growth Outlook, 2021- 2030
1.3 Neuropathic Pain Market Growth Opportunities to 2030
1.4 Key Neuropathic Pain Market Trends and Challenges
1.4.1 Neuropathic Pain Market Drivers and Trends
1.4.2 Neuropathic Pain Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Neuropathic Pain Companies
2. NEUROPATHIC PAIN MARKET SIZE OUTLOOK TO 2030
2.1 Neuropathic Pain Market Size Outlook, USD Million, 2021- 2030
2.2 Neuropathic Pain Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. NEUROPATHIC PAIN MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. NEUROPATHIC PAIN MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Indication
Diabetic Neuropathy
Spinal Stenosis
Chemotherapy-induced Peripheral Neuropathy
Others
By Drug Class
Tricyclic Antidepressants
Opioids
Capsaicin Cream
Steroids
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Neuropathic Pain Market, 2025
5.2 Asia Pacific Neuropathic Pain Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Neuropathic Pain Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Neuropathic Pain Market, 2025
5.5 Europe Neuropathic Pain Market Size Outlook by Type, 2021- 2030
5.6 Europe Neuropathic Pain Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Neuropathic Pain Market, 2025
5.8 North America Neuropathic Pain Market Size Outlook by Type, 2021- 2030
5.9 North America Neuropathic Pain Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Neuropathic Pain Market, 2025
5.11 South America Pacific Neuropathic Pain Market Size Outlook by Type, 2021- 2030
5.12 South America Neuropathic Pain Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Neuropathic Pain Market, 2025
5.14 Middle East Africa Neuropathic Pain Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Neuropathic Pain Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Neuropathic Pain Market Size Outlook and Revenue Growth Forecasts
6.2 US Neuropathic Pain Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Neuropathic Pain Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Neuropathic Pain Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Neuropathic Pain Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Neuropathic Pain Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Neuropathic Pain Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Neuropathic Pain Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Neuropathic Pain Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Neuropathic Pain Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Neuropathic Pain Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Neuropathic Pain Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Neuropathic Pain Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Neuropathic Pain Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Neuropathic Pain Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Neuropathic Pain Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Neuropathic Pain Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Neuropathic Pain Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Neuropathic Pain Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Neuropathic Pain Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Neuropathic Pain Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Neuropathic Pain Industry Drivers and Opportunities
7. NEUROPATHIC PAIN MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. NEUROPATHIC PAIN COMPANY PROFILES
8.1 Profiles of Leading Neuropathic Pain Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Centaur Pharmaceuticals Pvt. Ltd
Cipla Ltd
Dr. Reddy's Laboratories Ltd
GlaxoSmithKline plc
Glenmark Pharmaceuticals Ltd
Grьnenthal GmbH
Lannett Co Inc
Laurus Labs
Lupin Ltd
Mallinckrodt Pharmaceuticals
Pfizer Inc
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
